| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/07/1994 | US5318558 Osmotically driven delivery device with expandable orifice for pulsatile delivery effect |
| 06/07/1994 | US5318557 Medication administering device |
| 06/07/1994 | US5318524 Fibrin sealant delivery kit |
| 06/07/1994 | CA1330145C Protein label and drug delivery system |
| 06/07/1994 | CA1330139C Crosslinked polymers with carbonate ester groups, and a process for their preparation |
| 06/07/1994 | CA1330049C Process for removing pyrogens |
| 06/07/1994 | CA1330047C Oral compositions |
| 06/07/1994 | CA1330046C Treatment of periodontal disease |
| 06/07/1994 | CA1330042C Medicinal compositions based on brewers' grains extract, a process for the preparation thereof, and the use of brewers' grains extract for the preparation of cosmetic compositions, and a special brewers' grains extract |
| 06/07/1994 | CA1330041C Hydrophylic matrix salbutamol tablet and method for preparing such |
| 06/07/1994 | CA1330040C Lipid membrane structures |
| 06/05/1994 | CA2107694A1 Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization |
| 06/05/1994 | CA2102551A1 Use of ionic cloud point modifiers to prevent particle aggregation during sterilization |
| 06/03/1994 | CA2107280A1 Preparation and magnetic properties of very small magnetite-dextran particles |
| 06/01/1994 | EP0599767A1 Process to prepare water-dispersable tablets containing diclofenac |
| 06/01/1994 | EP0599543A1 Pharmaceutical preparation comprising fat emulsion of fat microparticles |
| 06/01/1994 | EP0599282A1 Pharmaceutical compositions containing ursodeoxycholic acid |
| 06/01/1994 | EP0599262A2 Stabilized superoxide-dismutase (SOD) compositions |
| 06/01/1994 | EP0599189A2 Proportioning device for extemporaneous multidose syrups for pharmaceutical use |
| 06/01/1994 | EP0599064A1 Retard form for pharmaceutically active agents |
| 06/01/1994 | EP0598989A1 Nutritional composition and process for its preparation |
| 06/01/1994 | EP0598905A1 STABILIZED IL-1$g(a) PHARMACEUTICAL PREPARATION |
| 06/01/1994 | EP0598719A1 Receptor conjugates for targeting drugs and other agents |
| 06/01/1994 | EP0583244A4 Method of producing zero-order controlled-release devices |
| 06/01/1994 | EP0577646A4 Sustained release drug delivery devices |
| 06/01/1994 | EP0571597A4 Method for treatment of acute and chronic painful arthropathic conditions in human and other mammals |
| 06/01/1994 | EP0569408A4 Wet powder film-forming compositions |
| 06/01/1994 | EP0523120B1 Film-forming product intended for coating solid forms |
| 06/01/1994 | EP0461108B1 Partially fused peptide pellet |
| 06/01/1994 | EP0321481B1 Microgranular preparation useful in the delivery of biologically active materials to the intestinal regions of animals |
| 06/01/1994 | EP0277211B1 Polymeric carrier compositions and methods for their preparation and use |
| 06/01/1994 | DE4342568A1 Chewing gum contg. caffeine - used as substitute for coffee, tea, cola, etc. and to control fatigue and migraine |
| 06/01/1994 | DE4244122C1 Lyophilisierte, wirkstoffhaltige Emulsion zur intravenösen Applikation Lyophilized drug-containing emulsion for intravenous administration |
| 06/01/1994 | CN1087277A Release-controlled somatotropin composition and method for prepartion thereof |
| 06/01/1994 | CN1087272A Traditional Chinese Medicine power capsule for curing chronic ischemic heart disease |
| 06/01/1994 | CN1087262A Controlied release oxycodone compositions |
| 06/01/1994 | CN1024754C Antibacterial lyophilized prepn. |
| 06/01/1994 | CN1024753C Method for preparing contraceptive implant |
| 05/31/1994 | US5317079 Fatty acid terminated polyanhydride |
| 05/31/1994 | US5317077 Polyarylates containing derivatives of the natural amino acid l-tyrosine |
| 05/31/1994 | US5317065 Poly amino dicarboxylic acid-co-anhydro amino dicarboxylic acid derivative |
| 05/31/1994 | US5316774 Blocked polymeric particles having internal pore networks for delivering active substances to selected environments |
| 05/31/1994 | US5316773 Solid preparation of 3-(3-(6-benzoyloxy-3-cyano-2-pyridyloxy-carbonyl)-benzoyl)-1-ethoxymethyl-5 -fluorouracil having enhanced water solubility |
| 05/31/1994 | US5316772 Bilayered oral pharmaceutical composition with pH dependent release |
| 05/31/1994 | US5316771 Method of amphiphatic drug loading in liposomes by ammonium ion gradient |
| 05/31/1994 | US5316761 Cosmetic gel stick compositions |
| 05/31/1994 | US5315998 Booster for therapy of diseases with ultrasound and pharmaceutical liquid composition containing the same |
| 05/28/1994 | CA2110087A1 Stabilised superoxide dismutase (sod) composition |
| 05/28/1994 | CA2109535A1 Proportioning device for extemporaneous multidose syrups for pharmaceutical use |
| 05/26/1994 | WO1994011394A2 Peptides with organo-protective activity, process for their preparation and their use in the therapy |
| 05/26/1994 | WO1994011100A1 Stable aqueous liposome suspension |
| 05/26/1994 | WO1994011023A1 Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof |
| 05/26/1994 | WO1994011010A2 Compositions of oak bark extract, related synthetic compositions, and method of using same |
| 05/26/1994 | WO1994010999A1 Transdermal therapeutic system for administering physostigmin through the skin, and a method of producing the system |
| 05/26/1994 | WO1994010998A1 Method of manufacturing composition for solid medicine |
| 05/26/1994 | WO1994010994A1 Ibuprofen salt effervescent compositions |
| 05/26/1994 | WO1994010993A1 Pharmaceutical formulations of ibuprofen |
| 05/26/1994 | WO1994010987A1 Combined analgesic delivery methods for pain management |
| 05/26/1994 | WO1994010986A1 Transdermal delivery of ketorolac |
| 05/26/1994 | WO1994010985A1 Transdermal delivery of the eutomer of a chiral drug |
| 05/26/1994 | WO1994010984A1 TRANSDERMAL THERAPEUTIC SYSTEM FOR THE RELEASE OF 17-β-ESTRADIOL AND PROCESS FOR ITS PRODUCTION |
| 05/26/1994 | WO1994010983A1 Peroral pharmaceutical preparation releasable in lower digestive tract |
| 05/26/1994 | WO1994010982A1 Sustained-release microsphere containing antipsychotic and process for producing the same |
| 05/26/1994 | WO1994010981A1 Prolonged-action pharmaceutical preparation |
| 05/26/1994 | WO1994010980A1 Compositions using microencapsulated neutralizing antibodies |
| 05/26/1994 | WO1994010979A1 Compositions of insoluble film-forming polymers and uses therefor |
| 05/26/1994 | WO1994010978A1 Method for the preparation of creams |
| 05/26/1994 | WO1994010976A1 Polyvinyl alcohol/borate ophthalmic drug delivery system |
| 05/26/1994 | WO1994010950A1 Microporous macrocapsules |
| 05/26/1994 | WO1994008571A3 Plaster for the transdermal administration of volatile, pharmaceutically active, chemically alkaline ingredients, and processs for producing the same |
| 05/26/1994 | WO1994004120A3 Methods of treating sexual dysfunction in animals with and h agonist |
| 05/26/1994 | DE4238223C1 Transdermales therapeutisches System zur Verabreichung von Physostigmin an die Haut und Verfahren zu dessen Herstellung Transdermal therapeutic system for the administration of physostigmine to the skin, and process for its preparation |
| 05/26/1994 | CA2148220A1 Method for producing composition for solid medicine |
| 05/25/1994 | EP0598606A1 Extrudable compositions for topical or transdermal drug delivery |
| 05/25/1994 | EP0598337A2 Pharmaceutical compositions including a drug, a cross-linked polymeric substance, an oil, and a surface active agent |
| 05/25/1994 | EP0598309A2 Multilayer matrix systems for the controlled release of active principles |
| 05/25/1994 | EP0598116A1 Fat emulsion |
| 05/25/1994 | EP0597933A1 Dental tray |
| 05/25/1994 | EP0566638A4 Flavor stable zinc acetate compositions for oral absorption |
| 05/25/1994 | EP0559768B1 Oral spiramycine formulations and method for preparing same |
| 05/25/1994 | EP0550641B1 Dispensing device containing a hydrophobic medium |
| 05/25/1994 | EP0476063B1 Glucan drug delivery system and adjuvant |
| 05/25/1994 | EP0357793B1 Suspended-release preparation prepared by using alginates |
| 05/25/1994 | CN2165849Y "Luofazai chun zhu" with medicines for treating alopecia |
| 05/25/1994 | CN1087026A Method of granulating crude drugs, and solid dosage forms |
| 05/25/1994 | CN1086999A External-use oinment for treating commonly encountered skin diseases |
| 05/25/1994 | CN1086997A A method of vasodilator therapy |
| 05/24/1994 | USRE34618 Solution with polyhydric alcohol; storage stability |
| 05/24/1994 | US5314921 Vehicle for oral administered drugs |
| 05/24/1994 | US5314917 Method for inactivating enveloped viruses and sperm |
| 05/24/1994 | US5314915 Sustained release of drug to mouth, gums |
| 05/24/1994 | US5314906 Derivatives of physostigmine, their use and pharmaceutical formulations containing them |
| 05/24/1994 | US5314904 Pharmaceutical compositions containing rifaximin for treatment of vaginal infections |
| 05/24/1994 | US5314872 Glucan sulfate, stabilized fibroblast growth factor composition |
| 05/24/1994 | US5314697 Stable extended release oral dosage composition comprising loratadine and pseudoephedrine |
| 05/24/1994 | US5314696 Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor |
| 05/24/1994 | US5314695 Tissue factor based prothrombin time reagent |
| 05/24/1994 | US5314694 Transdermal formulations, methods and devices |
| 05/24/1994 | US5314688 Local delivery of dipyridamole for the treatment of proliferative diseases |
| 05/24/1994 | US5314685 Skin disorders |